Veterinary Medicine Information website

Nobivac DHPPi

Authorised
  • Canine distemper virus, strain Onderstepoort, Live
  • Canine adenovirus 2, strain Manhattan LPV3, Live
  • Canine parvovirus, strain 154, Live
  • Canine parainfluenza virus, strain Cornell, Live
Download as PDF

Product identification

Medicine name:
Nobivac DHPPi
Active substance:
  • Canine distemper virus, strain Onderstepoort, Live
  • Canine adenovirus 2, strain Manhattan LPV3, Live
  • Canine parvovirus, strain 154, Live
  • Canine parainfluenza virus, strain Cornell, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine distemper virus, strain Onderstepoort, Live
    10000.00
    50% tissue culture infectious dose
    /
    1.00
    millilitre(s)
  • Canine adenovirus 2, strain Manhattan LPV3, Live
    10000.00
    50% tissue culture infectious dose
    /
    1.00
    millilitre(s)
  • Canine parvovirus, strain 154, Live
    10000000.00
    50% tissue culture infectious dose
    /
    1.00
    millilitre(s)
  • Canine parainfluenza virus, strain Cornell, Live
    316228.00
    50% tissue culture infectious dose
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate for solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AD04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Available in:
  • Ireland
Package description:
  • Clear, glass (Type I Ph.Eur) vials with halogenobutyl rubber stopper, closed with a colour coded aluminium cap.Cartons or plastic box with 10 single dose vials of vaccine lyophilisate
  • Clear, glass (Type I Ph.Eur) vials with halogenobutyl rubber stopper, closed with a colour coded aluminium cap.Cartons or plastic box with 50 single dose vials of vaccine lyophilisate

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10996/166/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 11/05/2025
Download